Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

[Chronicity practices - The integrated management for chronic conditions in the health district of Campi Salentina (Lecce ASL)].

Vantaggiato L, Maggio A, Lanzolla L, Metrangolo G, Mola E.

Ig Sanita Pubbl. 2015 Mar-Apr;71(2):195-204. Italian.

PMID:
26057176
2.

Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study.

Dougados M, Kissel K, Conaghan PG, Mola EM, Schett G, Gerli R, Hansen MS, Amital H, Xavier RM, Troum O, Bernasconi C, Huizinga TW.

Ann Rheum Dis. 2014 May;73(5):803-9. doi: 10.1136/annrheumdis-2013-204761. Epub 2014 Jan 28.

3.

Practice guidelines for the use of subcutaneous abatacept.

Mola EM, Balsa A, Martínez Taboada V, Marenco JL, Navarro Sarabia F, Gómez-Reino J, Alvaro-Gracia JM, Román Ivorra JA, Lojo L, Plasencia C, Carmona L.

Reumatol Clin. 2014 Jul-Aug;10(4):218-26. doi: 10.1016/j.reuma.2013.11.006. Epub 2014 Jan 1. Review. English, Spanish.

4.

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).

Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, Casado G, Detert J, El-Zorkany B, Emery P, Hajjaj-Hassouni N, Harigai M, Luo SF, Kurucz R, Maciel G, Mola EM, Montecucco CM, McInnes I, Radner H, Smolen JS, Song YW, Vonkeman HE, Winthrop K, Kay J.

Ann Rheum Dis. 2014 Jan;73(1):62-8. doi: 10.1136/annrheumdis-2013-204223. Epub 2013 Oct 4.

5.

Effect of grain size on the forces governing the dynamic behavior of electrostatically driven powder media.

Salvatierra LM, Dammig Quiña PL, Kovalevski LI, Irurzun IM, Mola EE.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Jun;87(6):062204. Epub 2013 Jun 25.

PMID:
23848668
6.

Effect of osteopathic manipulative treatment on length of stay in a population of preterm infants: a randomized controlled trial.

Cerritelli F, Pizzolorusso G, Ciardelli F, La Mola E, Cozzolino V, Renzetti C, D'Incecco C, Fusilli P, Sabatino G, Barlafante G.

BMC Pediatr. 2013 Apr 26;13:65. doi: 10.1186/1471-2431-13-65.

7.

Patient empowerment, an additional characteristic of the European definitions of general practice/family medicine.

Mola E.

Eur J Gen Pract. 2013 Jun;19(2):128-31. doi: 10.3109/13814788.2012.756866. Epub 2013 Jan 22.

PMID:
23336328
8.

Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY).

Dougados M, Kissel K, Sheeran T, Tak PP, Conaghan PG, Mola EM, Schett G, Amital H, Navarro-Sarabia F, Hou A, Bernasconi C, Huizinga TW.

Ann Rheum Dis. 2013 Jan;72(1):43-50. doi: 10.1136/annrheumdis-2011-201282. Epub 2012 May 5.

9.

Septic arthritis.

García-Arias M, Balsa A, Mola EM.

Best Pract Res Clin Rheumatol. 2011 Jun;25(3):407-21. doi: 10.1016/j.berh.2011.02.001. Review.

PMID:
22100289
10.

[The quality of interdisciplinary communication].

Manea S, Dalla Pozza LV, Mola E, Facchin P.

Ann Ig. 2011 Jul-Aug;23(4):303-10. Italian.

PMID:
22026233
11.

Radiation risks and family medicine.

Mola E, Visentin G.

Eur J Gen Pract. 2011 Sep;17(3):190-2. doi: 10.3109/13814788.2011.584528. Epub 2011 Jul 11. No abstract available.

PMID:
21745120
12.

Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative.

Gossec L, Paternotte S, Aanerud GJ, Balanescu A, Boumpas DT, Carmona L, de Wit M, Dijkmans BA, Dougados M, Englbrecht M, Gogus F, Heiberg T, Hernandez C, Kirwan JR, Mola EM, Cerinic MM, Otsa K, Schett G, Scholte-Voshaar M, Sokka T, von Krause G, Wells GA, Kvien TK.

Ann Rheum Dis. 2011 Jun;70(6):935-42. doi: 10.1136/ard.2010.142901.

PMID:
21540201
13.

Field fluctuations and fractality in electrical breakdown trees.

Dammig Quiña PL, Irurzun IM, Salvatierra LM, Mola EE.

Phys Rev E Stat Nonlin Soft Matter Phys. 2010 Oct;82(4 Pt 1):041106. Epub 2010 Oct 8.

PMID:
21230237
14.
15.

[Hip arthritis in an young adult - a diagnosis to consider].

Videira T, Miguel ED, Ventura FS, Mola EM.

Acta Reumatol Port. 2009 Oct-Dec;34(4):651-5. Portuguese.

16.

The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel.

Burmester G, Lanas A, Biasucci L, Hermann M, Lohmander S, Olivieri I, Scarpignato C, Smolen J, Hawkey C, Bajkowski A, Berenbaum F, Breedveld F, Dieleman P, Dougados M, MacDonald T, Mola EM, Mets T, Van den Noortgate N, Stoevelaar H.

Ann Rheum Dis. 2011 May;70(5):818-22. doi: 10.1136/ard.2010.128660. Epub 2010 Sep 10.

17.

Bioremediation of bacteria in aquaculture waste using the polychaete Sabella spallanzanii.

Stabili L, Schirosi R, Licciano M, Mola E, Giangrande A.

N Biotechnol. 2010 Dec 31;27(6):774-81. doi: 10.1016/j.nbt.2010.06.018. Epub 2010 Jul 7.

PMID:
20619371
18.

Feasibility and effectiveness of a disease and care management model in the primary health care system for patients with heart failure and diabetes (Project Leonardo).

Ciccone MM, Aquilino A, Cortese F, Scicchitano P, Sassara M, Mola E, Rollo R, Caldarola P, Giorgino F, Pomo V, Bux F.

Vasc Health Risk Manag. 2010 May 6;6:297-305.

19.

Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.

Gaujoux-Viala C, Smolen JS, Landewé R, Dougados M, Kvien TK, Mola EM, Scholte-Voshaar M, van Riel P, Gossec L.

Ann Rheum Dis. 2010 Jun;69(6):1004-9. doi: 10.1136/ard.2009.127225. Epub 2010 May 6. Review.

PMID:
20447954
20.

[Musculoskeletal ultrasonography in rheumatology].

Monteiro P, de Miguel E, Mola EM.

Acta Reumatol Port. 2009 Apr-Jun;34(2B):388-94. Portuguese.

21.

[Indicators of communication and degree of professional integration in healthcare].

Mola E, Maggio A, Vantaggiato L.

Ig Sanita Pubbl. 2009 May-Jun;65(3):271-86. Italian.

PMID:
19629153
22.

Etanercept in the longterm treatment of patients with ankylosing spondylitis.

Dijkmans B, Emery P, Hakala M, Leirisalo-Repo M, Mola EM, Paolozzi L, Salvarani C, Sanmarti R, Sibilia J, Sieper J, Van Den Bosch F, van der Heijde D, van der Linden S, Wajdula J.

J Rheumatol. 2009 Jun;36(6):1256-64. doi: 10.3899/jrheum.081033. Epub 2009 May 1. Erratum in: J Rheumatol. 2010 Oct;37(10):2198.

PMID:
19411393
23.

[Foreign body reaction to palm leaf].

Falcão S, Gamero F, Miguel Ed, Mourão AF, Pimentão JB, Branco JC, Mola EM.

Acta Reumatol Port. 2009 Jan-Mar;34(1):136-7. Portuguese. No abstract available.

24.

Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure.

Fernández-Montequín JI, Betancourt BY, Leyva-Gonzalez G, Mola EL, Galán-Naranjo K, Ramírez-Navas M, Bermúdez-Rojas S, Rosales F, García-Iglesias E, Berlanga-Acosta J, Silva-Rodriguez R, Garcia-Siverio M, Martinez LH.

Int Wound J. 2009 Feb;6(1):67-72. doi: 10.1111/j.1742-481X.2008.00561.x.

PMID:
19291119
25.

Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative.

Gossec L, Dougados M, Rincheval N, Balanescu A, Boumpas DT, Canadelo S, Carmona L, Daurès JP, de Wit M, Dijkmans BA, Englbrecht M, Gunendi Z, Heiberg T, Kirwan JR, Mola EM, Matucci-Cerinic M, Otsa K, Schett G, Sokka T, Wells GA, Aanerud GJ, Celano A, Dudkin A, Hernandez C, Koutsogianni K, Akca FN, Petre AM, Richards P, Scholte-Voshaar M, Von Krause G, Kvien TK.

Ann Rheum Dis. 2009 Nov;68(11):1680-5. doi: 10.1136/ard.2008.100271. Epub 2008 Dec 3.

PMID:
19054825
26.

Integrating patient empowerment as an essential characteristic of the discipline of general practice/family medicine.

Mola E, De Bonis JA, Giancane R.

Eur J Gen Pract. 2008;14(2):89-94. doi: 10.1080/13814780802423463.

PMID:
18821139
27.

A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects.

Martínez-Taboada VM, Rodríguez-Valverde V, Carreño L, López-Longo J, Figueroa M, Belzunegui J, Mola EM, Bonilla G.

Ann Rheum Dis. 2008 May;67(5):625-30. Epub 2007 Dec 17.

PMID:
18086726
28.

The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.

van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, Freundlich B, Chang DJ; Etanercept Study 400 Investigators.

Ann Rheum Dis. 2008 Feb;67(2):182-8. Epub 2007 Aug 29.

PMID:
17728331
29.

[Play as an therapeutic educational tool].

Mola E, Chauvière J.

Soins. 2007 Apr;(714 Suppl):S20, S22-3. French. No abstract available.

PMID:
17569277
30.

Validation of the Italian version of the EUROPEP instrument for patient evaluation of general practice care.

Milano M, Mola E, Collecchia G, Del Carlo A, Giancane R, Visentin G, Nicolucci A.

Eur J Gen Pract. 2007;13(2):92-4.

PMID:
17534746
31.

Front waves in the NO + NH3 reaction on Pt{100}.

Irurzun IM, Mola EE, Imbihl R.

J Phys Chem A. 2007 May 3;111(17):3313-20. Epub 2007 Apr 7.

PMID:
17417826
32.

The structure of the chiral Pt531 surface: a combined LEED and DFT study.

Puisto SR, Held G, Ranea V, Jenkins SJ, Mola EE, King DA.

J Phys Chem B. 2005 Dec 1;109(47):22456-62.

PMID:
16853925
33.

Scaling properties in the average number of attempts until saturation in random sequential adsorption processes.

Bea AE, Irurzun IM, Mola EE.

Phys Rev E Stat Nonlin Soft Matter Phys. 2006 May;73(5 Pt 1):051604. Epub 2006 May 15.

PMID:
16802943
34.

How many Langmuirs are required for monolayer formation?

Bea AE, Irurzun IM, Mola EE.

Langmuir. 2005 Nov 8;21(23):10871-3.

PMID:
16262365
35.

Dielectric breakdown model for composite materials.

Peruani F, Solovey G, Irurzun IM, Mola EE, Marzocca A, Vicente JL.

Phys Rev E Stat Nonlin Soft Matter Phys. 2003 Jun;67(6 Pt 2):066121. Epub 2003 Jun 30.

PMID:
16241318
36.

Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.

Carmona L, Gómez-Reino JJ, Rodríguez-Valverde V, Montero D, Pascual-Gómez E, Mola EM, Carreño L, Figueroa M; BIOBADASER Group.

Arthritis Rheum. 2005 Jun;52(6):1766-72.

37.

Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis.

Calin A, Dijkmans BA, Emery P, Hakala M, Kalden J, Leirisalo-Repo M, Mola EM, Salvarani C, Sanmartí R, Sany J, Sibilia J, Sieper J, van der Linden S, Veys E, Appel AM, Fatenejad S.

Ann Rheum Dis. 2004 Dec;63(12):1594-600. Epub 2004 Sep 2.

38.

Dielectric breakdown model for conductor-loaded and insulator-loaded composite materials.

Bergero P, Peruani F, Solovey G, Irurzun IM, Vicente JL, Mola EE.

Phys Rev E Stat Nonlin Soft Matter Phys. 2004 Jan;69(1 Pt 2):016123. Epub 2004 Jan 30.

PMID:
14995683
39.
40.

Theoretical model of diatomic molecules interacting on a two-dimensional lattice.

Mola EE, Ranea V, Vicente JL.

Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1999 Nov;60(5 Pt A):5130-4.

PMID:
11970380
41.

WHO Collaborating Centre consensus meeting on anti-cytokine therapy in rheumatoid arthritis.

Emery P, Reginster JY, Appelboom T, Breedveld FC, Edelmann E, Kekow J, Malaise M, Mola EM, Montecucco C, Sanda M, Sany J, Scott DL, Serni U, Seydoux G.

Rheumatology (Oxford). 2001 Jun;40(6):699-702.

PMID:
11426031
42.

Fractal analysis of electrical trees in a cross-linked synthetic resin.

Irurzun IM, Vicente JL, Cordero MC, Mola EE.

Phys Rev E Stat Nonlin Soft Matter Phys. 2001 Jan;63(1 Pt 2):016110. Epub 2000 Dec 21.

PMID:
11304317
43.

EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT).

Pendleton A, Arden N, Dougados M, Doherty M, Bannwarth B, Bijlsma JW, Cluzeau F, Cooper C, Dieppe PA, Günther KP, Hauselmann HJ, Herrero-Beaumont G, Kaklamanis PM, Leeb B, Lequesne M, Lohmander S, Mazieres B, Mola EM, Pavelka K, Serni U, Swoboda B, Verbruggen AA, Weseloh G, Zimmermann-Gorska I.

Ann Rheum Dis. 2000 Dec;59(12):936-44.

44.

Leg bone pain syndrome in a kidney transplant patient treated with tacrolimus (FK506)

Villaverde V, Cantalejo M, Balsa A, Mola EM.

Ann Rheum Dis. 1999 Oct;58(10):653-4. No abstract available.

45.

Normotensive renal failure in a patient with systemic sclerosis and p-antineutrophil cytoplasmic autoantibodies which developed into Paget's disease of bone after immunosuppressive therapy.

Villaverde V, Balsa A, Cabezas JA, Fernández-Prada M, Torre A, Mola EM.

Rheumatology (Oxford). 1999 Feb;38(2):190-1. No abstract available.

PMID:
10342639
46.

Potential-barrier model at metal surfaces: Application to analyses of low-energy electron-diffraction fine-structure experiments.

Mola EE, Paola CA, Vicente JL.

Phys Rev B Condens Matter. 1991 Dec 15;44(24):13671-13677. No abstract available.

PMID:
9999572
47.

Enhancement of cryoprecipitation from hypotonic serum: a comparative study in normals and in patients with connective tissue diseases.

Mola EM, Gharavi AE, Joshi VR, Patel BM, Colaco CB, Hughes GR.

Clin Exp Rheumatol. 1983 Jan-Mar;1(1):35-40.

PMID:
6681122

Supplemental Content

Support Center